ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GDR Genedrive Plc

1.90
-0.025 (-1.30%)
27 Sep 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.025 -1.30% 1.90 1.85 1.95 1.925 1.875 1.93 2,880,688 12:32:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0095 -2.00 10.46M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 1.93p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 13.50p.

Genedrive currently has 543,141,481 shares in issue. The market capitalisation of Genedrive is £10.46 million. Genedrive has a price to earnings ratio (PE ratio) of -2.00.

Genedrive Share Discussion Threads

Showing 5176 to 5197 of 32525 messages
Chat Pages: Latest  209  208  207  206  205  204  203  202  201  200  199  198  Older
DateSubjectAuthorDiscuss
08/2/2021
16:03
If Danagher should want a buyout we could be looking at over £10 a share
swerves1
08/2/2021
15:59
Yes but deal in bag this time with beckman
yasyas1
08/2/2021
15:57
is this guy for real? You seriously knocking this share right now...lol
jambam
08/2/2021
15:56
One thing I can say for absolute certainty........don't trust a single word from oilsgold . He Ramps then deramps according to his position and one of the most disgusting dishonest posters I've come across. I have no position here at all but wish genuine holders good luck
mcrudden
08/2/2021
15:50
The CEO didnt even RNS at 7am. The share price was left to spike before LAMBS GOT FLEECED
oilisgold
08/2/2021
15:47
Where can you see that Hooded Claw? All we can establish is that they are now under 3%
aimsuperfan
08/2/2021
15:43
BGF out :)
hooded claw
08/2/2021
15:41
Dont get spiked at 300p again. Placing for sure. CEO cant be trusted
oilisgold
08/2/2021
15:41
Be carefull all. PLACING BEING ARRANGED I RECKON AT 100P. THESE BIG BOYS Want rinse and repeat.
oilisgold
08/2/2021
15:40
£3 here we come...
neo26
08/2/2021
15:35
Beckman and coulter deal is material and significant for gdr, david budd words.They can aggressively distribute the product.Mkt cap is way too low...
neo26
08/2/2021
15:22
Struggling around this price as we are approx 200% up from 39p
hooded claw
08/2/2021
15:19
No way. I m almost at my buy price
yasyas1
08/2/2021
15:17
Zac Mir 200p price target will get smashed very soon at this rate. Hold Hold Hold don't sell your shares cheap. Strong Buy
seball
08/2/2021
15:03
115p is a real pain. However after 120p my guess is that it will be clearer waters up until 150p. All can change if news comes first though.
aimsuperfan
08/2/2021
14:18
"Does the test take into account the new variants ? This could be key in the future." - Yes
hooded claw
08/2/2021
14:16
Cheers neo26 !
fuji99
08/2/2021
14:14
David Budd, CEO of genedrive plc said: "We have carried out detailed in silico analysis of 155,276 sequences on the GISAID database. The results show that the test is able to detect all published COVID-19 strains with the same high level of accuracy and demonstrates 100% homology."
neo26
08/2/2021
14:08
Does the test take into account the new variants ? This could be key in the future.
fuji99
08/2/2021
13:44
So many buyers loading up ,not even 2pm yet ,more investors loading up before middle of Month

Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing


David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously.



"We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."



The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations.

bunz3
08/2/2021
13:15
Still trying to shake the weak but they are less and less now
hooded claw
08/2/2021
13:09
I think this has longevity.
hazl
Chat Pages: Latest  209  208  207  206  205  204  203  202  201  200  199  198  Older